Skip to main content
SpringerLink
Log in

Bioprospecting Model for a New Colombia Drug Discovery Initiative in the Pharmaceutical Industry

  • Chapter
  • First Online:
Analysis of Science, Technology, and Innovation in Emerging Economies

Abstract

In these times of environmental and global threats that prompt the emergence of infectious diseases, new challenges require new initiatives for developing therapeutics and bringing them to market, for obtaining commitments from the market, and for acquiring public research and development funding. Organizational models have emerged to expedite these initiatives, such as public–private partnerships and not-for-profit product development partnerships, including the Drugs for Neglected Diseases Initiative, the Medicines for Malaria Venture, and the Global Alliance for Tuberculosis Drug Development. One promising approach in relation to drug discovery that captures the natural value of biodiversity is bioprospecting: in order to treat disease, this multidisciplinary line combines ecology, pharmacology, and therapeutics in the search for new chemical entities from organisms native to tropical rain forests and other ecosystems. Their effectiveness inevitably varies, but the International Cooperative Biodiversity Groups program of the National Institutes of Health identifies several advantages in terms of economic growth and in other ways: they help to prevent biodiversity loss, promote the building of scientific capacity and the protection of intellectual property rights in developing countries, and boost the search for new biological resources. Nearly 30% of the new drugs approved by the Food and Drug Administration between 2008 and 2012 originated from natural products, which, to extrapolate from biodiversity analyses under the Nagoya Protocol, indicates a large source for new drugs and potentially a large market for them. Furthermore, it has been estimated that the benefits in this area come from preclinical research, and that 17% of pharmaceutical research is being undertaken by small companies; these firms are developing projects to evaluate the biological consequences of biodiversity in order to develop new products, and they produce a third of the new drugs entering the market. Finally, this chapter shows the potential of Colombian biodiversity for the pharmaceutical industry in a model that maintains the link between conservation and bioprospecting in order to achieve sustainable economic development connected to human health.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 16.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Arundel, A., & Sawaya, D. (2009). The Bioeconomy to 2030: Designing a Policy Agenda. Retrieved from http://www.oecd.org/futures/longtermtechnologicalsocietalchallenges/thebioeconomyto2030designingapolicyagenda.htm

  • Amandine, B. (2010). Technological Choices in International Environmental Negotiations: An Actor—Network Analysis. Business & Society, 49(4), 570–590.

    Article  Google Scholar 

  • Balconi, M., & Lorenzi, V. (2017). The Increasing Role of Contract Research Organizations in the Evolution of the Biopharmaceutical Industry. African Journal of Business Management, 11(18), 478–490.

    Article  Google Scholar 

  • Billette de Villemeur, E., & Versaevel, B. (2017). One Lab, Two Firms, Many Possibilities: On R&D outsourcing in the Biopharmaceutical Industry. Retrieved from https://mpra.ub.uni-muenchen.de/76903/1/MPRA_paper_76903.pdf

  • Bueno, J. (2017a). Bioprospecting and Drug Development, Parameters for a Rational Search and Validation of Biodiversity. Journal of Microbial and Biochemical Technology, 9, e128.

    Article  Google Scholar 

  • Bueno, J. (2017b). Fungal Bionanotechnology, When Knowledge Merge into a New Discipline to Combat Antimicrobial Resistance. In Fungal Nanotechnology (pp. 189–206). Cham: Springer.

    Chapter  Google Scholar 

  • Bueno, J., Demirci, F., & Baser, K. H. C. (2017). Antimicrobial Strategies in Novel Drug Delivery Systems: Applications in the Treatment of Skin and Soft Tissue Infections. In The Microbiology of Skin, Soft Tissue, Bone and Joint Infections (pp. 271–286). Boston: Academic Press.

    Google Scholar 

  • Cagliano, A. C., Grimaldi, S., & Rafele, C. (2015). Choosing Project Risk Management Techniques. A Theoretical Framework. Journal of Risk Research, 18(2), 232–248.

    Article  Google Scholar 

  • Cheng, X., Zhao, S. G., Xiao, X., & Chou, K. C. (2017). iATC-mHyb: A Hybrid Multi-label Classifier for Predicting the Classification of Anatomical Therapeutic Chemicals. Oncotarget, 8(35), 58494.

    Google Scholar 

  • Chesher, D. (2008). Evaluating Assay Precision. The Clinical Biochemist Reviews, 29(Suppl 1), S23.

    Google Scholar 

  • Colombia, C. N. Ley 1753 de 2015 Por la cual se expide el Plan Nacional de Desarrollo 2014–2018 todos por un nuevo país. Bogotá DC: DNP Departamento Nacional de Planeación. Retrieved from https://colaboracion.dnp.gov.co/CDT/PND/PND%202014-2018%20Tomo%201%20internet.pdf

  • Consejo privado de competitividad. (2016). Índice departamental de competitividad. Retrieved from https://compite.com.co/wp-content/uploads/2016/07/CPC_IDC-2016.pdf

  • Cotes Prado, A. M., Meneses, B., Villamizar, L. S. R., Mogollón, F. Z., Martínez, M. V. A., & Prado, H. A. M. C. (2012). Bioprospección para el desarrollo del sector agropecuario de Colombia (No. Doc. 26007) CO-BAC, Bogotá.

    Google Scholar 

  • De Witt, A., Osseweijer, P., & Pierce, R. (2017). Understanding Public Perceptions of Biotechnology Through the “Integrative Worldview Framework”. Public Understanding of Science, 26(1), 70–88.

    Article  Google Scholar 

  • Departamento Administrativo de Ciencia, Tecnología e Innovación (COLCIENCIAS). (2017). Resolución 0036 de 2017 por “La cual se adoptan los lineamientos de la presentación de proyectos de oferta institucional de inversión en Ciencia, Tecnología e Innovación”. Retrieved from http://www.colciencias.gov.co/sites/default/files/upload/reglamentacion/resolucion-0036-2017.pdf

  • Departamento Nacional de Planeación. (2011). Documento CONPES 3697, Política para el desarrollo comercial de la biotecnología a partir del uso sostenible de la biodiversidad. Retrieved from https://www.cbd.int/doc/measures/abs/post-protocol/msr-abs-co-es.pdf

  • DiMasi, J. A., Grabowski, H. G., & Hansen, R. W. (2016). Innovation in the Pharmaceutical Industry: New Estimates of R&D Costs. Journal of Health Economics, 47, 20–33.

    Article  Google Scholar 

  • Domínguez Molina, Á. M. (2012). Aproximación al estado actual de la bioprospección en Colombia y propuesta para la implementación del plan nacional en bioprospección. Master’s thesis, Facultad de Estudios Ambientales y Rurales. Retrieved from https://repository.javeriana.edu.co/bitstream/handle/10554/12379/DominguezMolinaAngelaMaria2012.pdf?sequence=1

  • Díaz, B. M. V., Gallo, J. J., & Plazas, C. E. (2016). Propuesta de una metodología para el estudio de competencia tecnológica, en empresas fabricantes de medicamentos. Universidad & Empresa, 18(31), 11–27.

    Article  Google Scholar 

  • Erden, Z. (2017). The Publishing and Patenting Strategies of Successful University Spinoffs in the Biopharmaceutical Industry. Drug Discovery Today, 22(1), 5–9.

    Article  Google Scholar 

  • Feigembaun, A. V. (1991). Key Systems Activities for Total Quality Control. In A. V. Feigembaun (Ed.), Total Quality Control (p. 94). Estados Unidos: McGraw-Hill.

    Google Scholar 

  • Firn, R. D. (2003). Bioprospecting–Why Is It So Unrewarding? Biodiversity & Conservation, 12(2), 207–216.

    Article  Google Scholar 

  • Food and Drug Administration. (2016). Novel New Drugs, 2015 Summary. Retrieved from https://www.fda.gov/downloads/drugs/developmentapprovalprocess/druginnovation/ucm481709.pdf

  • Gallón, A. I. M. (2011). La biodiversidad y la biotecnología en la facultad de química farmacéutica de la Universidad de Antioquia, a propósito del documento conpes 3697 de 2011. Vitae, 18(2), 111–113.

    Google Scholar 

  • Gautam, A., & Pan, X. (2016). The Changing Model of Big Pharma: Impact of Key Trends. Drug Discovery Today, 21(3), 379–384.

    Article  Google Scholar 

  • Gonzales, C., Villa, J. M., & Velasco, R. (2007). Biotecnología: desde el punto de vista de los negocios. Facultad de Ciencias Agropecuarias, 5(1), 36–41.

    Google Scholar 

  • Goyes, D. R., & South, N. (2015). Land-grabs, Biopiracy and the Inversion of Justice in Colombia. British Journal of Criminology, 56(3), 558–577.

    Article  Google Scholar 

  • Griesenauer, R. H., & Kinch, M. S. (2017). 2016 in Review: FDA Approvals of New Molecular Entities. Drug Discovery Today, 22(11), 1593–1597.

    Article  Google Scholar 

  • Hernández, M. C. (2008). Propuesta de apoyo para una Gestión eficiente de la biotecnología. Revista Escuela de Administración de Negocios, 62.

    Google Scholar 

  • Hernández, R. S., & Miranda, P. P. (2015). Una mirada a la industria farmacéutica en Colombia. REVISTA FACCEA, 4(2), 107–115.

    Google Scholar 

  • Hover, B. M., Kim, S. H., Katz, M., Charlop-Powers, Z., et al. (2018). Culture-independent Discovery of the Malacidins as Calcium-dependent Antibiotics with Activity Against Multidrug-resistant Gram-positive Pathogens. Nature Microbiology, 3(4), 415–422.

    Article  Google Scholar 

  • ICH Harmonized Tripartite. (2005). Validation of Analytical Procedures: Text and Methodology. Q2 (R1), Vol. 1.

    Google Scholar 

  • Jiménez, T., Cárdenas, J., & Soler-Tovar, D. (2017). Biocomercio en el contexto suramericano: Colombia y Perú como estudios de caso. Revista de Medicina Veterinaria, 35, 9–15.

    Article  Google Scholar 

  • Kang, K. N., Jung, C. S., & Ryu, T. K. (2015). The Nagoya Protocol and the Biotechnology Industry. International Journal of Pharma Medicine and Biological Sciences, 4(3), 209.

    Google Scholar 

  • Kamuriwo, D. S., & Baden-Fuller, C. (2016). Knowledge Integration Using Product R&D Outsourcing in Biotechnology. Research Policy, 45(5), 1031–1045.

    Article  Google Scholar 

  • Kerzner, H., & Kerzner, H. R. (2017). Project Management: A Systems Approach to Planning, Scheduling, and Controlling. New York: John Wiley & Sons.

    Google Scholar 

  • Kusari, S., Singh, S., & Jayabaskaran, C. (2014). Biotechnological Potential of Plant-associated Endophytic Fungi: Hope Versus Hype. Trends in Biotechnology, 32(6), 297–303.

    Article  Google Scholar 

  • Map, T. (2015). Trade Statistics for International Business Development. In Geneva, Switzerland: International Trade Centre (United Nations Conference on Trade and Development-World Trade Organization). Retrieved from http://www.trademap.org

  • Marín, C., & Parra, S. (2015). Bitácora de flora. Guía visual de plantas de páramos de Colombia. Retrieved from repository.humboldt.org.co/bitstream/handle/20.500.11761/9283/BitacoraFLORA-Agosto11-Final_Digital.pdf?sequence=1&isAllowed=y

  • Mazzucato, M. (2015). The Green Entrepreneurial State. In I. Scoones, M. Leach, & P. Newell, (Eds.), The Politics of Green Transformations (pp. 134–152). London: Routledge.

    Google Scholar 

  • Mendoza, C. A. S. (2014). Análisis de los indicadores de biocomercio en America (Colombia). Asuntos Económicos y Administrativos, 27, 331–341.

    Google Scholar 

  • Mendoza-Ruiz, A., Acosta, A., Escamilla, E. P. V., & Torres, M. C. L. (2017). Pharmaceutical Policy in Colombia. In Pharmaceutical Policy in Countries with Developing Healthcare Systems (pp. 193–219). Springer International Publishing.

    Google Scholar 

  • Ministerio de Agricultura y Desarrollo Rural. (2017). Plan Estratégico de Ciencia Tecnología e Innovación del Sector Agropecuario Colombiano para la Agroindustria (PECTIA) y Sistema Nacional de Innovación Agropecuario (SNIA). Retrieved from http://www.colombiacompetitiva.gov.co/sncei/Documents/pectia-terminado.pdf

  • Montero, J. M. S. (2011, December). Biotecnología: presente y futuro. In Anales de la Real Academia Nacional de Farmacia (Vol. 77, No. 4).

    Google Scholar 

  • Moreno, L. A., Andrade, G. I., & Ruíz-Contreras, L. F. (Eds.). (2016). Biodiversidad 2016. Estado y tendencias de la biodiversidad continental de Colombia. Instituto de Investigación de Recursos Biológicos Alexander von Humboldt. Bogotá, DC, Colombia, p. 106. Retrieved from http://repository.humboldt.org.co//handle/20.500.11761/32962

  • Moscoso, F., Estrada, F., Diaz, N., & Andrade, N. (2015). Obstacles to Progress in R&D Activities Caused by Institutional and Regulatory Frameworks: The Case of the Biotech Sector in Colombia. Research in World Economy, 6(4), 116.

    Article  Google Scholar 

  • Paddon, C. J., & Keasling, J. D. (2014). Semi-synthetic Artemisinin: A Model for the Use of Synthetic Biology in Pharmaceutical Development. Nature Reviews Microbiology, 12(5), 355.

    Article  Google Scholar 

  • Pan, P. G. (2006). Bioprospecting: Issues and Policy Considerations. Legislative Reference Bureau. Retrieved from http://www.angelfire.com/planet/big60/BioprospectingCommitsionReport.pdf

  • Prip, C., & Rosendal, K. (2015). Access to Genetic Resources and Benefit-sharing from Their Use (ABS)-state. World, 9(2), 189–212.

    Google Scholar 

  • Purkayastha, J. (2016). Emerging Trends in Sustainable Bioprospecting of Bioresources. In Bioprospecting of Indigenous Bioresources of North-East India (pp. 3–19). Singapore: Springer.

    Google Scholar 

  • Pushpangadan, P., Ijinu, T. P., Dan, V. M., & George, V. (2015). Trends in Bioprospecting of Biodiversity in New Drug Design. Pleione, 9(2), 267–282.

    Google Scholar 

  • Pyka, A., & Prettner, K. (2018). Economic Growth, Development, and Innovation: The Transformation Towards a Knowledge-Based Bioeconomy. In Bioeconomy (pp. 329–340). Cham: Springer.

    Google Scholar 

  • Quezada, F. (2003). Biotechnology-based Opportunities for the Sustainable Use of Biodiversity Resources in the Andean Region: Recommendations and Strategic Guidelines. Retrieved from http://citeseerx.ist.psu.edu/viewdoc/download;jsessionid=153B57C474F06F5FC1C3DC9B7B0536B3?doi=10.1.1.488.170&rep=rep1&type=pdf

  • Rangel, J. O. (2015). La biodiversidad de Colombia: significado y distribución regional. Palimpsestvs, Revista de la Academia Colombiana de Ciencias Exactas. Físicas y Naturales, 39(151), 176–200.

    Google Scholar 

  • Rodríguez, J. M., Camargo, J. C., Niño, J., Pineda, A. M., Arias, L. M., Echeverry, M. A., & Miranda, C. L. (2009). Valoración de la Biodiversidad en la Ecorregión del Eje Cafetero. Pereira: CIEBREG.

    Google Scholar 

  • Sahoo, N., & Bhattacharya, S. S. (2017). Intellectual Property Rights Protection in Plants: Scopes in Lychee Commercialization. In The Lychee Biotechnology (pp. 281–299). Singapore: Springer.

    Chapter  Google Scholar 

  • Schaffartzik, A., Haberl, H., Kastner, T., Wiedenhofer, D., Eisenmenger, N., & Erb, K. H. (2015). Trading Land: A Review of Approaches to Accounting for Upstream Land Requirements of Traded Products. Journal of Industrial Ecology, 19(5), 703–714.

    Article  Google Scholar 

  • Schuhmacher, A., Gassmann, O., & Hinder, M. (2016). Changing R&D Models in Research-based Pharmaceutical Companies. Journal of Translational Medicine, 14(1), 105.

    Article  Google Scholar 

  • Schulze, U., Ringel, M., Panier, V., & Baedeker, M. (2017). Market Watch: Value of 2016 FDA Drug Approvals: Reversion to the Mean? Nature Reviews Drug Discovery, 16(2), 78–78.

    Article  Google Scholar 

  • Sellés, A. J. N. (2014). Pharma R&D in Latin America. Pharmaceuticals Policy and Law, 16(3, 4), 267–275.

    Article  Google Scholar 

  • Jr Silva, G., Silveira, J. M., Paranhos, J., Hasenclever, L., & Miranda, R. (2017). Innovation, Market Power and Biotechnology in the Brazilian Chemical Industry. Economics Bulletin, 37(2), 1210–1216.

    Google Scholar 

  • Singh, B. K. (2017). Creating New Business, Economic Growth and Regional Prosperity Through Microbiome-based Products in the Agriculture Industry. Microbial Biotechnology, 10(2), 224–227.

    Article  Google Scholar 

  • Srivastava, S. K. (2016). Commercial Use of Biodiversity: Resolving the Access and Benefit Sharing Issues. New Delhi: SAGE Publications India.

    Google Scholar 

  • Superintendencia de Industria y Comercio-SIC, Centro de Información Tecnológica y Apoyo a la Gestión de la Propiedad Industrial – CIGEPI. (2015). Productos fitoterapéuticos. Retrieved from http://www.sic.gov.co/recursos_user/documentos/publicaciones/Productos_Fitoterapeuticos.pdf

  • Suri, F. K., & Banerji, A. (2016). Super Generics—First Step of Indian Pharmaceutical Industry in the Innovative Space in US Market. Journal of Health Management, 18(1), 161–171.

    Article  Google Scholar 

  • Torre, B. G., & Albericio, F. (2017). The Pharmaceutical Industry in 2016. An Analysis of FDA Drug Approvals from a Perspective of the Molecule Type. Molecules, 22(3), 368.

    Article  Google Scholar 

  • Unkles, S. E., Valiante, V., Mattern, D. J., & Brakhage, A. A. (2014). Synthetic Biology Tools for Bioprospecting of Natural Products in Eukaryotes. Chemistry & Biology, 21(4), 502–508.

    Article  Google Scholar 

  • Vargas-Hernández, J. G., Pallagst, K., & Hammer, P. (2017). Bio Economy’s Institutional and Policy Framework for the Sustainable Development of Nature’s Ecosystems. Atlantic Review of Economics, 2, 1–30.

    Google Scholar 

  • Villar, L., Salazar, N., Pérez, C., Orbegozo, C., & Mesa, C. A. (2015). Informe del sector farmacéutico colombiano-FEDESARROLLO-ANDI. Retrieved from http://www.repository.fedesarrollo.org.co/bitstream/handle/11445/2481/Repor_Julio_2015_Fedesarrollo_y_ANDI.pdf?sequence=3&isAllowed=y

  • Vásquez Velásquez, J., Gómez Portilla, K., & Rodríguez Acosta, S. (2010). Regulación en el mercado farmacéutico colombiano. Revista de Ciencias Sociales (Ve), 16(2).

    Google Scholar 

  • Wyatt, T., & Brisman, A. (2017). The Role of Denial in the ‘Theft of Nature’: Comparing Biopiracy and Climate Change. Critical Criminology, 25(3), 325–341.

    Article  Google Scholar 

  • Zanello, G., Fu, X., Mohnen, P., & Ventresca, M. (2016). The Creation and Diffusion of Innovation in Developing Countries: A Systematic Literature Review. Journal of Economic Surveys, 30(5), 884–912.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Research Center of Bioprospecting and Biotechnology for Biodiversity Foundation (BIOLABB), Bogotá, Colombia

    Juan Bueno & Sebastian Ritoré

Authors
  1. Juan Bueno
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sebastian Ritoré
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Juan Bueno .

Editor information

Editors and Affiliations

  1. School of Management, Universidad del Rosario, Bogotá, Colombia

    Clara Inés Pardo Martínez

  2. Universidad Santo Tomás, Bogotá, Colombia

    Alexander Cotte Poveda

  3. Colombian Observatory of Science and Technology (OCyT), Bogotá, Colombia

    Sylvia Patricia Fletscher Moreno

Rights and permissions

Reprints and permissions

Copyright information

© 2019 The Author(s)

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Bueno, J., Ritoré, S. (2019). Bioprospecting Model for a New Colombia Drug Discovery Initiative in the Pharmaceutical Industry. In: Pardo Martínez, C., Cotte Poveda, A., Fletscher Moreno, S. (eds) Analysis of Science, Technology, and Innovation in Emerging Economies. Palgrave Macmillan, Cham. https://doi.org/10.1007/978-3-030-13578-2_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-13578-2_3

  • Published:

  • Publisher Name: Palgrave Macmillan, Cham

  • Print ISBN: 978-3-030-13577-5

  • Online ISBN: 978-3-030-13578-2

  • eBook Packages: Social SciencesSocial Sciences (R0)

Publish with us

Policies and ethics

Search

Navigation